{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-022209","form_type":"8-K","ticker":"SKIN","cik":"0001818093","company_name":"SkinHealth Systems Inc.","filed_at":"2024-05-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.328113+00:00","generated_at":"2026-06-02T06:47:41.701489+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"BeautyHealth Q1 net sales $81.4M, -5.7% YoY; net loss narrows to $0.7M","bullets":["Delivery systems net sales $35.8M (down 21% from $45.4M); consumables $45.6M (up from $40.9M).","Net loss improved to ($0.7M) from ($20.3M); adjusted EBITDA $0.4M vs ($0.5M) YoY.","Repurchased $192.3M of convertible notes through May 8.","Gross margin 59.4% (adjusted 63.4%) vs 62.7% (adjusted 70.0%) a year ago.","Active install base 32,530, up from 27,406; 1,417 delivery systems sold vs 1,774."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-022209","json":"https://secwatch.observer/filing/0001628280-24-022209.json","markdown":"https://secwatch.observer/filing/0001628280-24-022209.md","text":"https://secwatch.observer/filing/0001628280-24-022209.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1818093/000162828024022209/0001628280-24-022209-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1818093/000162828024022209/skin-20240509.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T06:47:41.701489+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"81ef7954118c5680b60ef1ee8dbb21d56a5b06a6","claim":"SkinHealth Systems Inc. reported financial results for first quarter ended March 31, 2024.","evidence_excerpt":"On May 9, 2024, The Beauty Health Company (the “Company”) issued a press release and will hold a conference call regarding its financial results for its quarter ended March 31, 2024.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1818093/000162828024022209/0001628280-24-022209-index.htm","confidence":0.85,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2024"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}